-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ON+65uTmeTJI9NhcDahNSbsgUq0JhMfp7d7xNu7RPoqorJM0X8fo7DOdNNaSmR9W VuRDqLz13ifIpe6pnpH5Jg== 0000909012-07-001216.txt : 20070829 0000909012-07-001216.hdr.sgml : 20070829 20070829171930 ACCESSION NUMBER: 0000909012-07-001216 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070829 DATE AS OF CHANGE: 20070829 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: HUDSON HOLDING CORP CENTRAL INDEX KEY: 0000804157 STANDARD INDUSTRIAL CLASSIFICATION: SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211] IRS NUMBER: 411546471 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-39281 FILM NUMBER: 071088531 BUSINESS ADDRESS: STREET 1: 111 TOWN SQUARE PLACE, STREET 2: SUITE 1500A CITY: JERSEY CITY STATE: NJ ZIP: 07310 BUSINESS PHONE: 201-216-0100 MAIL ADDRESS: STREET 1: 111 TOWN SQUARE PLACE, STREET 2: SUITE 1500A CITY: JERSEY CITY STATE: NJ ZIP: 07310 FORMER COMPANY: FORMER CONFORMED NAME: HEALTH OUTCOMES MANAGEMENT INC DATE OF NAME CHANGE: 19951116 FORMER COMPANY: FORMER CONFORMED NAME: DATA MED CLINICAL SUPPORT SERVICES INC /MN/ DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Cunningham Martin Craig CENTRAL INDEX KEY: 0001326283 FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: BUSINESS PHONE: (201) 216-0100 MAIL ADDRESS: STREET 1: 525 WASHINGTON BLVD. CITY: JERSEY CITY STATE: NJ ZIP: 07310 SC 13D 1 t303690.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Hudson Holding Corporation ------------------------------------------------------------------------------- (Name of Issuer) Common Stock, $.001 par value per share ------------------------------------------------------------------------------- (Title of Class of Securities) 443793104 ------------------------------------------------------------------------------- (CUSIP Number) David Selengut, Esq. Ellenoff Grossman & Schole LLP 370 Lexington Avenue New York, New York 10017 212-370-1300 ------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) August 8, 2007 ------------------------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box: |_| . The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act. CUSIP No. 443793104 - -------------------------------------------------------------------------------- 1) Name of Reporting Persons: Martin Cunningham I.R.S. Identification Nos. of Above Persons (entities only) - -------------------------------------------------------------------------------- 2) Check the Appropriate Box if a Member of a Group (See Instructions) (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3) SEC Use Only - -------------------------------------------------------------------------------- 4) Source of Funds (See Instructions) PF - -------------------------------------------------------------------------------- 5) Check if Disclosure of Legal Proceedings is Required Pursuant To Items 2(d) or 2(e) |_| - -------------------------------------------------------------------------------- 6) Citizenship Or Place Of Organization United States of America - -------------------------------------------------------------------------------- (7) Sole Voting Power 5,003,565 ------------------------------------------------- Number of (8) Shared Voting Power Shares 0 Beneficially Owned ------------------------------------------------- By Each Reporting (9) Sole Dispositive Power Person With 5,003,565 - ------------------------------------------------------------------------------- (10) Shared Dispositive Power 0 - -------------------------------------------------------------------------------- 11) Aggregate Amount Beneficially Owned by Each Reporting Person 5,003,565 - -------------------------------------------------------------------------------- 12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares |_| - -------------------------------------------------------------------------------- 13) Percent of Class Represented by Amount in Row (11) Approximately 13.6% - -------------------------------------------------------------------------------- 14) Type of Reporting Person IN - -------------------------------------------------------------------------------- Item 1. Security and Issuer This Schedule 13D is filed on behalf of Martin Cunningham relating to the acquisition of 825,000 shares of common stock, par value $0.001 per share (the "Shares"), of Hudson Holding Corporation., a Delaware corporation ("Hudson"). The address of the principal executive offices of the Issuer is 111 Town Square Place, Suite 1500A, Jersey City, New Jersey 07310 Item 2. Identity & Background This statement is filed on behalf of: (a) Martin Cunningham (b) 525 Washington Blvd., Jersey City, NJ 07310 (c) The Reporting Person is the Chief Executive Officer and Chairman of the Issuer. (d) The Reporting Person has not, during the past five (5) years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). (e) The Reporting Person has not during the past five (5) years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and, as a result of such proceeding, subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. (f) The Reporting Person is a United States citizen. Item 3 Source and Amount of Funds or Other Consideration All Shares were acquired through cash purchase from personal funds of the reporting person. Item 4. Purpose of Transaction The Reporting Person acquired the Shares for personal investment. The Reporting Person has no present plans or intentions which would result in, or relate to, any transactions as described in subparagraphs (b) through (j) of Item 4 of Schedule 13D. Item 5. Interest in Securities of the Issuer (a), (b) The Reporting Person beneficially owns 5,003,565 Shares, or 13.6% of the outstanding shares of Common Stock entitled to vote. The Reporting Person has sole voting power and dispositive power of all the shares of Common Stock he beneficially owns. (c) On August 8, 2007, the Reporting Person acquired 825,000 Shares through a private purchase. (d) Not applicable. (e) Not applicable. Item 6. Contract, Arrangements, Understandings, or Relationships with respect to Securities of the Issuer Not applicable. Item 7. Material to be Filed as Exhibits Not applicable. Signature After reasonable inquiry, and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. Dated: August 22, 2007 /s/ Martin Cunningham ---------------------- Martin Cunningham -----END PRIVACY-ENHANCED MESSAGE-----